01Ask what is specified at the point of supply

For a dried material, distinguish gross mass from assigned peptide content and identify any declared excipients. For a solution, identify the concentration basis, solvent or buffer composition, volume and molecular form.

These records answer different immediate questions. A powder mass does not directly provide a solution concentration, while a concentration statement needs the volume and amount basis to establish how much peptide is supplied.

The comparison should reflect the intended experiment. A convenient format still needs the documentary basis required by that experiment; convenience cannot establish equivalence between two formulations.

02The dried state is not a universal stability advantage

Bersin, Patel and Topp studied pyroglutamate formation in a model peptide in solution and lyophilised solids. Under their elevated-temperature study conditions, the apparent pH dependence differed between the two states.Bersin, Patel and Topp — Pyroglutamate formation in solution and lyophilised solids (opens in a new tab)

In part of the examined formulation range, the solid-state reaction proceeded faster than the corresponding solution reaction. The result challenges a blanket assumption that drying must slow every degradation pathway.Bersin, Patel and Topp — Pyroglutamate formation in solution and lyophilised solids (opens in a new tab)

It does not establish a shelf life for any commercial research peptide. The experiment investigated a particular sequence, formulation set and reaction under defined stress conditions.

For a format decision, ask whether the available stability evidence actually covers the proposed form. A result for a solution cannot be transferred to the dried formulation merely by keeping the peptide name unchanged.

03A change of form can introduce another comparison

A study of a modified vasoactive intestinal peptide with a non-covalent PEG-containing system reported changes after lyophilisation and reconstitution, including an approximately 10% decrease in solubility and a similar decrease in helical conformation.A combined strategy for physical PEGylation of polypeptides (opens in a new tab)

Those observations concern a specifically engineered peptide–polymer formulation. They are not a predicted loss for ordinary research vials, but they show why the transition between forms can itself be an experimental question.

If the planned study requires a solution at the measurement stage, evidence for the supplied dried material and evidence for the eventual measured sample are connected but separate. The final sample should not inherit every original claim without an established link.

04Make the format choice reviewable

Write the choice as a short justification: the experimental system requires specified composition and amount information; the selected material provides those data; these remaining uncertainties require clarification.

If the alternatives have different formulations, avoid describing the decision as a pure powder-versus-solution comparison. Several variables may be changing together, and a later difference cannot automatically be attributed to physical form alone.

This approach leaves operational details to the laboratory’s material-specific procedures. It supports a clear procurement or study decision without inventing preparation instructions, universal storage temperatures or a generic period of use.